Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DNAI2 anticorps (C-Term)

DNAI2 Reactivité: Humain WB Hôte: Lapin Polyclonal RB41653 unconjugated
N° du produit ABIN1881264
  • Antigène Voir toutes DNAI2 Anticorps
    DNAI2 (Dynein, Axonemal, Intermediate Chain 2 (DNAI2))
    Épitope
    • 13
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 484-513, C-Term
    Reactivité
    • 28
    • 6
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 24
    • 4
    Lapin
    Clonalité
    • 26
    • 2
    Polyclonal
    Conjugué
    • 18
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp DNAI2 est non-conjugé
    Application
    • 28
    • 19
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This DNAI2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 484-513 amino acids from the C-terminal region of human DNAI2.
    Clone
    RB41653
    Isotype
    Ig Fraction
    Top Product
    Discover our top product DNAI2 Anticorps primaire
  • Indications d'application
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Date de péremption
    6 months
  • Loges, Olbrich, Fenske, Mussaffi, Horvath, Fliegauf, Kuhl, Baktai, Peterffy, Chodhari, Chung, Rutman, OCallaghan, Blau, Tiszlavicz, Voelkel, Witt, Zietkiewicz, Neesen, Reinhardt, Mitchison, Omran: "DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm." dans: American journal of human genetics, Vol. 83, Issue 5, pp. 547-58, (2008) (PubMed).

    Pennarun, Chapelin, Escudier, Bridoux, Dastot, Cacheux, Goossens, Amselem, Duriez: "The human dynein intermediate chain 2 gene (DNAI2): cloning, mapping, expression pattern, and evaluation as a candidate for primary ciliary dyskinesia." dans: Human genetics, Vol. 107, Issue 6, pp. 642-9, (2001) (PubMed).

    Hanna, Kruskal, Ezekowitz, Bloom, Collier: "Role of macrophage oxidative burst in the action of anthrax lethal toxin." dans: Molecular medicine (Cambridge, Mass.), Vol. 1, Issue 1, pp. 7-18, (1996) (PubMed).

  • Antigène
    DNAI2 (Dynein, Axonemal, Intermediate Chain 2 (DNAI2))
    Autre désignation
    DNAI2 (DNAI2 Produits)
    Synonymes
    anticorps MGC115449, anticorps CILD9, anticorps DIC2, anticorps C030015H18Rik, anticorps Dnai2, anticorps Gm728, anticorps Dnaic2, anticorps dynein axonemal intermediate chain 2, anticorps dynein axonemal intermediate chain 2 S homeolog, anticorps dynein, axonemal, intermediate chain 2, anticorps DNAI2, anticorps dnai2.S, anticorps dnai2, anticorps Dnaic2, anticorps Dnai2
    Sujet
    The protein encoded by this gene belongs to the dynein intermediate chain family, and is part of the dynein complex of respiratory cilia and sperm flagella. Mutations in this gene are associated with primary ciliary dyskinesia type 9. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
    Poids moléculaire
    68821
    NCBI Accession
    NP_001166281, NP_075462
    UniProt
    Q9GZS0
Vous êtes ici:
Support technique